• The BNN has performed a survey among his members about patient written consent for Botulinum Toxin injections and Dr Miles  Humberstone presented the results at the BNN 2017 annual meeting in Oxford,  followed by a discussion from the BNN members.
  • It  was noted that although the majority ( 57%) of surveyed BNN members routinely take written consent prior to first Botulinum Toxin injection, a significant minority do not. Botulinum toxin consent BNN survey.
  • There was a consensus of opinion that a consent form in itself is not a robust defense against complaint or litigation, but a majority of BNN members do regularly use written consent and a number of members described the reasons for their adoption of this process, chiefly as a part of formalizing and documenting the consent process.
  • The letter to GP with copy to patient was also used by members to document the oral or written consent from the patient.
  • Among those who do not take written consent, time constraints within the clinic were cited as the main reason.
  • During the presentation the lack of widespread availability of  information sheets for Botulinum Toxin injection became apparent and it was agreed that an information sheet would also be made available.